英格兰GBMSM与医务人员对4CMenB淋病疫苗认知的质性焦点小组研究
本研究通过3组17名GBMSM和1组5名性健康专业人员的焦点小组讨论,用主题分析结合疫苗接受连续体与社会生态模型解读。参与者总体持积极态度,但估计有效性30-35%被视为中等,影响主动寻求接种意愿;结构限制与严格资格标准是公平接种的障碍。
要点
- GBMSM与HCPs对4CMenB淋病疫苗总体持积极态度,视为支持性健康并减少焦虑。
- 估计有效性30-35%被视为中等,未降低接受度但降低主动寻求接种的意愿。
- 预约可及性有限与资格标准严格是公平接种的主要障碍,社区化 delivery 受支持。
核心结论
- 4CMenB淋病疫苗对参与研究的GBMSM和HCPs可接受,但接种 uptake 可能取决于获取便利性、清晰沟通与系统层面支持。
- 解决结构性限制并支持社区化 delivery 可能有助于实现4CMenB的公平提供。
研究设计与样本
- 质性焦点小组研究:3组焦点小组讨论纳入17名≥18岁、居住在英格兰、自报过去12个月有细菌性性传播感染或≥5名性伴侣的GBMSM。
- 另1组焦点小组讨论纳入5名性健康专业人员(HCPs)。
- 数据采用主题分析,并借助疫苗接受连续体(Vaccine Uptake Continuum)与社会生态模型(Social Ecological Model)组织与解读。
主要发现
- 参与GBMSM和HCPs普遍对4CMenB接种表达积极认知。
- GBMSM将接种描述为支持性健康并减少对淋病的焦虑。
- 估计有效性30-35%被视为中等,但未阻碍可接受性,却降低了主动寻求接种的意愿。
- 结构性限制(如预约可及性有限)与限制性资格标准被识别为公平接种的障碍。
- 社区化 delivery 模式被支持为改善可及性的潜在途径;HCPs借鉴mpox接种经验预判实施挑战并强调清晰指南与可持续资源。
关键数值与推荐
- 参与研究的GBMSM与HCPs对4CMenB淋病疫苗的估计有效性为30-35%。
临床怎么用
- 在性健康服务中推进4CMenB接种时,应优先简化预约流程与资格认定以降低结构性障碍。
- 沟通中需清晰说明30-35%的估计有效性,同时维持接种可接受性并促进主动寻求接种。
- 可探索社区化 delivery 模式以改善公平可及,并借鉴mpox接种经验配套清晰指南与可持续资源。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In November 2023, the Joint Committee on Vaccination and Immunisation advised the UK government to introduce a targeted, opportunistic vaccination programme using 4CMenB in sexual health services to prevent gonorrhoea primarily in gay, bisexual and other men who have sex with men (GBMSM) at higher risk of infection. Evidence on4CMenB vaccination acceptability was required. METHODS: Three focus group discussions (FGDs) were conducted with 17 GBMSM aged ≥18 years, resident in England, who self-reported bacterial sexually transmitted infection or ≥ 5 sexual partners in the previous 12-months, alongside one FGD with five sexual healthcare professionals (HCPs). Data were analysed using thematic analysis and organised and interpreted using the Vaccine Uptake Continuum and the Social Ecological Model. RESULTS: Participating GBMSM and HCPs generally expressed positive perceptions of 4CMenB vaccination. GBMSM described vaccination as supporting sexual wellbeing and reducing anxiety about gonorrhoea. While the estimated effectiveness (30-35%) was perceived as modest, it did not deter acceptability but reduced willingness to actively seek vaccination. Structural constraints (e.g. limited appointment availability) and restrictive eligibility criteria were identified as barriers to equitable uptake. Community-based delivery models were supported as a potential approach to improve access. HCPs drew on mpox vaccination experience to anticipate implementation challenges and emphasised clear guidance and sustainable resourcing. Additional protection against meningitis was generally a secondary influence. CONCLUSIONS: 4CMenB vaccination for gonorrhoea was acceptable to participating GBMSM and HCPs; however, uptake is likely to depend on ease of access, clear communication, and system-level support. Addressing structural constraints and supporting community-based delivery may help achieve equitable delivery of 4CMenB.
引用
- Osman R, Jajja A, Weil B, et al. Exploring perceptions of 4CMenB vaccination for gonorrhoea prevention among gay, bisexual and other men who have sex with men and healthcare professionals in England: a qualitative focus group study. Vaccine. 2026. PMID: 42962461. doi:10.1016/j.vaccine.2026.129232
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。